For the Inventor, By the Inventor

Enter assignee name

Cham, Switzerland

Galderma S.a.

USPTO Granted Patents = 86

CIPO Patents = 13

EPO Patents = 78

Trademarks = 27

Forward Citations = 258

Loading Chart...

Loading Chart...

136 inventors (with patents filed for the assignee):

Philippe Andres (10 out of 13 patents)

Alexandre Kaoukhov (9 out of 9 patents)

Jean Jacovella (8 out of 10 patents)

4. Claire Mallard (8 out of 33 patents)

5. Laurent Chantalat (8 out of 18 patents)

6. Vincent Manetta (7 out of 8 patents)

7. Gary R Watkins (7 out of 8 patents)

8. Jean-Paul Chappuis (6 out of 6 patents)

9. Nathalie Willcox (6 out of 17 patents)

10. Jeffrey D Parks (6 out of 6 patents)

11. L Dean Parks (6 out of 15 patents)

12. Sandrine Segura-Orsoni (6 out of 7 patents)

13. Jerry Roth (6 out of 8 patents)

14. Nancy Puglia (6 out of 7 patents)

15. Rosario Ramirez (6 out of 7 patents)

Core Competencies:

Pharmaceutical Composition

Indigo Naturalis Extract

Avermectin Compounds

Hyaluronic Acid

Topical Skin Care

Dermatological Conditions

Acne Treatment

Rosacea Treatment

Atopic Dermatitis

Cross-Linked Products

Glycosaminoglycans

Macrocyclic Lactone

86 patents: Sort by Forward Citations

1. 11116811 - Pharmaceutical composition comprising refined indigo naturalis extracts and the use thereof (2021-09-14),

2. 10899894 - Method for preparing acylated crosslinked glycosaminoglycans (2021-01-26),

3. 10857306 - Syringe (2020-12-08),

4. 10849854 - Process for preparing a composition comprising a high concentration of one or more avermectins (2020-12-01),

5. 10745493 - Graft copolymer (2020-08-18),

6. 10695391 - Extract from Indigo Naturalis and a process for preparing the same (2020-06-30),

7. 10688117 - Topical wash composition for use in acne patients (2020-06-23),

8. 10668120 - Antibacterial indigo naturalis or indigo-producing plant extract and use thereof (2020-06-02),

9. 10653659 - Compositions comprising a compound from the family of avermectins and an agonist compound for at least one of the retinoic acid receptors for treating acne (2020-05-19),

10. 10610594 - BPO wash gel composition (2020-04-07),

11. 10555985 - Pharmaceutical composition comprising refinedextracts and the use thereof (2020-02-11),

12. 10533061 - Grafting of cyclodextrin by amide bonds to an ether cross-linked hyaluronic acid and uses thereof (2020-01-14),

13. 10463643 - Composition comprising a compound from the family of avermectins and doxycycline for the treatment of rosacea (2019-11-05),

14. 10398720 - Compound of the avermectin family or of the milbemycin family for the treatment and/or prevention of atopic dermatitis (2019-09-03),

15. 10376492 - Use of a macrocyclic lactone for treating a complication from a papilloma virus infection (2019-08-13),

Galderma is a global pharmaceutical company specializing in dermatology and skin health. With a diverse portfolio of medical solutions, Galderma aims to enhance the quality of life for patients and healthcare providers. By focusing on innovation, research, and partnerships, Galderma develops and markets a wide range of prescription drugs, over-the-counter products, and aesthetic solutions. Dedicated to meeting patient needs, Galderma operates in more than 100 countries, offering advanced skincare treatments and solutions for common and rare skin disorders.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

86 Patents

#3 in Cham

#176 in Switzerland

#8,577 in the World

Cham, Switzerland

Galderma S.a.

Forward Citations = 258

136 inventors:

Philippe Andres (10 out of 13 patents)

Alexandre Kaoukhov (9 out of 9 patents)

Jean Jacovella (8 out of 10 patents)

4. Claire Mallard (8 out of 33 patents)

5. Laurent Chantalat (8 out of 18 patents)

Please report any incorrect information to support@idiyas.com

Loading…